Merit Financial Group, LLC Eli Lilly & CO Transaction History

Merit Financial Group, LLC

$4.59 Billion
Q3 2024

A detailed history of Merit Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Merit Financial Group, LLC holds 14,244 shares of LLY stock, worth $11.2 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

14,244

Previous 15,615 8.78%

Holding current value

$11.2 Million

Previous $14.1 Million 10.74%

% of portfolio

0.28%

Previous 0.3%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$772.14 - $960.02 $1.06 Million - $1.32 Million	-1,371 Reduced 8.78%	14,244 $12.6 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $1.85 Million - $2.32 Million	2,553 Added 19.55%	15,615 $14.1 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $5.05 Million - $6.76 Million	8,528 Added 188.09%	13,062 $10.2 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $2.64 Million - $3.11 Million	-5,024 Reduced 52.56%	4,534 $2.64 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $101,719 - $140,236	234 Added 2.51%	9,558 $5.13 Million
Q2 2023 Aug 01, 2023	BUY	$350.74 - $468.98 $569,601 - $761,623	1,624 Added 21.09%	9,324 $4.37 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $497,318 - $584,076	1,601 Added 26.25%	7,700 $2.64 Million
Q4 2022 Jan 13, 2023	BUY	$321.55 - $374.67 $380,393 - $443,234	1,183 Added 24.06%	6,099 $0
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $1.21 Million - $1.38 Million	-4,089 Reduced 45.41%	4,916 $1.59 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $2.31 Million - $2.71 Million	8,270 Added 1125.17%	9,005 $2.92 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $172,497 - $214,370	735 New	735 $210,000

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.

Account

Merit Financial Group, LLC Eli Lilly & CO Transaction History